Early Phase 1 Type 1 Diabetes Trial, Recruiting (NCT06470295)

Early Phase 1 Type 1 Diabetes Trial, Recruiting NCT06470295 Sponsor: University of Cincinnati Condition: Type 1 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT06470295 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 1 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have a Body Mass Index (BMI) of less than 30, meaning you are not classified as obese (you can check your BMI using an online calculator with your height and weight)

Who may not be able to join:

Women who are currently pregnant or breastfeeding
People who currently smoke cigarettes
People who have HIV or hepatitis
People who have been diagnosed with a heart or blood vessel disease (cardiovascular disease)
People who have damage to their small blood vessels (a condition called microvascular disease, which can affect the eyes, kidneys, or nerves — confirm with trial site if unsure whether this applies to you)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Principal Investigator: Jason Winnick, PhD, University of Cincinnati

Phone: 513-558-4437

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06470295

Sponsor: University of Cincinnati

Phase: Early Phase 1

Status: Recruiting

Condition: Type 1 Diabetes

Trial contact: 513-558-4437

More information: https://clinicaltrials.gov/study/NCT06470295

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have a Body Mass Index (BMI) of less than 30, meaning you are not classified as obese (you can check your BMI using an online calculator with your height and weight)

Who may not be able to join:

Women who are currently pregnant or breastfeeding
People who currently smoke cigarettes
People who have HIV or hepatitis
People who have been diagnosed with a heart or blood vessel disease (cardiovascular disease)
People who have damage to their small blood vessels (a condition called microvascular disease, which can affect the eyes, kidneys, or nerves — confirm with trial site if unsure whether this applies to you)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Early Phase 1

Sponsor

University of Cincinnati

Registry

ClinicalTrials.gov

Start date

1 June 2024

Est. completion

1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Glucagon

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov